(Q50195575)

26 February 2018

title

Incidence, severity, and prevention of infections in chronic granulomatous disease. (English)

1 reference

26 February 2018

1 reference

Mouy R

1

1 reference

26 February 2018

Fischer A

2

1 reference

26 February 2018

Vilmer E

3

1 reference

26 February 2018

Seger R

4

1 reference

26 February 2018

Griscelli C

5

1 reference

26 February 2018

language of work or name

English

0 references

publication date

1 April 1989

1 reference

26 February 2018

The Journal of Pediatrics

published in

1 reference

26 February 2018

volume

114

1 reference

26 February 2018

page(s)

555-560

1 reference

26 February 2018

issue

4 Pt 1

1 reference

26 February 2018

In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Defective candidacidal capacity of polymorphonuclear leukocytes in chronic granulomatous disease of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Deficient flavoprotein component of the NADPH-dependent O2-.-generating oxidase in the neutrophils from three male patients with chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

A Variant of Chronic Granulomatous Disease: Deficient Oxidative Metabolism Due to a Low-Affinity NADPH Oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

The X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Chronic familial granulomatosis. Report of five cases and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Agents responsible for infection in chronic granulomatous disease of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

NIH conference. Recent advances in chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Quantitative nitroblue tetrazolium test in chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Kinetics of oxygen consumption by phagocytosing human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

A study of 25 patients with chronic granulomatous disease: a new classification by correlating respiratory burst, cytochrome b, and flavoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Fungal infection in chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Aspergillosis complicating neoplastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Serologic immunodiagnosis of of invasive aspergillosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b-positive neutrophils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Chronic granulomatous disease, a heterogeneous syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Chronic granulomatous disease of childhood: a changing pattern?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim (SMX-TMP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

The antifungal activity of ketoconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

Laboratory and clinical assessment of ketoconazole in deep-seated mycoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980693-6

10.1016/S0022-3476(89)80693-6

7 January 2021

Identifiers

DOI

1 reference

26 February 2018

PubMed ID

2784499

1 reference

26 February 2018